GenVec, Inc.
Industry
- Pharmaceuticals
- Drug Delivery
- Site Specific
- Macromolecule
- Vaccines
- Drug Delivery
- Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
Latest on GenVec, Inc.
Bristol-Myers Squibb Co. has appointed Saurabh Saha senior vice president and global head of translational medicine. Saha joins BMS from Atlas Venture, where he held leadership positions with it
There are no therapies currently available for hearing loss that protect or restore hearing, Decibel Therapeutics ' CEO Steven Holtzman told Scrip, describing the area as a "white space." The con
The field of gene therapy is heating up again, with candidates advancing toward late-stage trials and eventual submission to FDA. The extra resources and attention provided by FDA's breakthrough thera
IN VITRO DIAGNOSTICS Mergers & Acquisitions Luminex Corp. Nanosphere Inc. Luminex Corp. is paying $77mm ($1.70 per share; a 63% premium) in cash to acquire molecular diagnostics firm Nanosphere